|
|
Volumn 296, Issue 2, 2006, Pages 155-157
|
|
Trials probe new agents for kidney cancer
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
INTERLEUKIN 2;
LAPATINIB;
PLATELET DERIVED GROWTH FACTOR RECEPTOR;
SUNITINIB;
TEMSIROLIMUS;
VASCULOTROPIN RECEPTOR;
ANEMIA;
ANGIOGENESIS;
CANCER SURVIVAL;
CLINICAL TRIAL;
DRUG MECHANISM;
DRUG POTENTIATION;
DYSPNEA;
FATIGUE;
HUMAN;
IMMUNOTHERAPY;
KIDNEY CANCER;
KIDNEY CARCINOMA;
PRIORITY JOURNAL;
SHORT SURVEY;
WEAKNESS;
|
|
EID: 33745889033
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.296.2.155 Document Type: Short Survey |
|
Times cited : (8)
|
|
References (0)
|